Cibinqo® (abrocitinib) is a daily medicine for moderate to severe atopic dermatitis. Atopic dermatitis is also known as eczema. Cibinqo is useful for adults with atopic dermatitis that has not responded well to other drugs or biologics. It is also useful for people who are not able to take other medicines or biologics for atopic dermatitis. Cibinqo is a Janus kinase 1 (JAK1) inhibitor. These inhibitors are a new class of drugs for people with atopic dermatitis. Many experts view JAK inhibitors as a breakthrough in the treatment of atopic dermatitis . . .
Published in AtopicDermatitis.net on February 4, 2022
